Lori A. Leslie, MD | Authors


Questioning Future Combinations and Targets for CAR T Cell in DLBCL

February 25, 2020

Lori A. Leslie, MD, discusses chimeric antigen receptor T-cell therapy as a treatment for diffuse large B-cell lymphoma and the positive results demonstrated for this agent in patients with relapsed/refractory disease.